Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New HER2 inhibitors presented by Taiho Pharmaceutical

Aug. 6, 2020

Betta Pharmaceuticals divulges EGFR mutant inhibitors

Aug. 6, 2020

p53 plays role of Dr. Jekyll or Mr. Hyde in gastric cancer

Aug. 6, 2020

Huya Bioscience obtains worldwide rights to SHP-2 inhibitor

Aug. 6, 2020

SEMA3C identified as promising therapeutic target in bladder cancer

Aug. 5, 2020

BiSiChem identifies new ALK inhibitors

Aug. 5, 2020

Biogen synthesizes new IRAK-4 inhibitors

Aug. 5, 2020

Minghui Pharmaceutical presents new BTK inhibitors

Aug. 5, 2020

Picturing molecular alterations

Aug. 5, 2020

Tasquinimod treatment begins in phase Ib/IIa multiple myeloma study

Aug. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...